SEC Form 4 · accession 0001127602-18-011328
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George M Milne Jr.
Director
Period of report
Mar 9, 2018
Accepted (ET)
Mar 13, 2018 · 11:43 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 9, 2018 | M | 7,740 | $40.27 | A | 36,760 | D | |
| Common Stock | Mar 9, 2018 | S | 7,740 | $115.00 | D | 29,020 | D | |
| Common Stock | holding | — | — | — | 1,000 | I | Held By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $40.27 | Mar 9, 2018 | M | 7,740 | D | May 11, 2012 | May 11, 2018 | Common Stock | 7,740 | 0 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.